BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 22186710)

  • 21. Quantitative measurement of syndesmophyte volume and height in ankylosing spondylitis using CT.
    Tan S; Yao J; Flynn JA; Yao L; Ward MM
    Ann Rheum Dis; 2014 Mar; 73(3):544-50. PubMed ID: 23345598
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Bone morphogenetic proteins and Dickkopf-1 in ankylosing spondylitis.
    Liao HT; Lin YF; Tsai CY; Chou TC
    Scand J Rheumatol; 2018 Jan; 47(1):56-61. PubMed ID: 28303752
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Factors associated with serum soluble inhibitors of Wnt-β-catenin signaling (sclerostin and dickkopf-1) in patients undergoing peritoneal dialysis.
    Yamada S; Tsuruya K; Tokumoto M; Yoshida H; Ooboshi H; Kitazono T
    Nephrology (Carlton); 2015 Sep; 20(9):639-45. PubMed ID: 25974190
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The relationship between inhibitors of the Wnt signalling pathway (Dickkopf-1(DKK1) and sclerostin), bone mineral density, vascular calcification and arterial stiffness in post-menopausal women.
    Hampson G; Edwards S; Conroy S; Blake GM; Fogelman I; Frost ML
    Bone; 2013 Sep; 56(1):42-7. PubMed ID: 23702386
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Suppression of Sclerostin and Dickkopf-1 levels in patients with fluorine bone injury.
    Wang W; Xu J; Liu K; Liu X; Li C; Cui C; Zhang Y; Li H
    Environ Toxicol Pharmacol; 2013 May; 35(3):402-7. PubMed ID: 23467116
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Elevated serum level of hepatocyte growth factor predicts development of new syndesmophytes in men with ankylosing spondylitis.
    Deminger A; Klingberg E; Nurkkala M; Geijer M; Carlsten H; Jacobsson LTH; Forsblad-d'Elia H
    Rheumatology (Oxford); 2021 Apr; 60(4):1804-1813. PubMed ID: 33106846
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The VEGF and BMP-2 levels in patients with ankylosing spondylitis and the relationship to treatment with tumour necrosis factor alpha inhibitors.
    Tošovský M; Bradna P; Andrýs C; Andrýsová K; Cermáková E; Soukup T
    Acta Medica (Hradec Kralove); 2014; 57(2):56-61. PubMed ID: 25257151
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Fetuin-A is related to syndesmophytes in patients with ankylosing spondylitis: a case control study.
    Tuylu T; Sari I; Solmaz D; Kozaci DL; Akar S; Gunay N; Onen F; Akkoc N
    Clinics (Sao Paulo); 2014 Dec; 69(10):688-93. PubMed ID: 25518021
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Circulating sclerostin and Dickkopf-1 (DKK1) in predialysis chronic kidney disease (CKD): relationship with bone density and arterial stiffness.
    Thambiah S; Roplekar R; Manghat P; Fogelman I; Fraser WD; Goldsmith D; Hampson G
    Calcif Tissue Int; 2012 Jun; 90(6):473-80. PubMed ID: 22527202
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Correlation of blood bone turnover biomarkers and Wnt signaling antagonists with AS, DISH, OPLL, and OYL.
    Niu CC; Lin SS; Yuan LJ; Chen LH; Yang CY; Chung AN; Lu ML; Tsai TT; Lai PL; Chen WJ
    BMC Musculoskelet Disord; 2017 Feb; 18(1):61. PubMed ID: 28153008
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Association of markers of bone- and cartilage-degradation with radiological changes at baseline and after 2 years follow-up in patients with ankylosing spondylitis.
    Vosse D; Landewé R; Garnero P; van der Heijde D; van der Linden S; Geusens P
    Rheumatology (Oxford); 2008 Aug; 47(8):1219-22. PubMed ID: 18539620
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Altered skeletal expression of sclerostin and its link to radiographic progression in ankylosing spondylitis.
    Appel H; Ruiz-Heiland G; Listing J; Zwerina J; Herrmann M; Mueller R; Haibel H; Baraliakos X; Hempfing A; Rudwaleit M; Sieper J; Schett G
    Arthritis Rheum; 2009 Nov; 60(11):3257-62. PubMed ID: 19877044
    [TBL] [Abstract][Full Text] [Related]  

  • 33. High disease activity in ankylosing spondylitis is associated with increased serum sclerostin level and decreased wingless protein-3a signaling but is not linked with greater structural damage.
    Korkosz M; Gąsowski J; Leszczyński P; Pawlak-Buś K; Jeka S; Kucharska E; Grodzicki T
    BMC Musculoskelet Disord; 2013 Mar; 14():99. PubMed ID: 23509994
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Sclerostin and Dickkopf-1 in post-menopausal renal allograft recipients.
    Tomei P; Zaza G; Granata S; Gatti D; Fraccarollo C; Gesualdo L; Boschiero L; Lupo A
    Transplant Proc; 2014 Sep; 46(7):2241-6. PubMed ID: 25242761
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of recent spinal cord injury on wnt signaling antagonists (sclerostin and dkk-1) and their relationship with bone loss. A 12-month prospective study.
    Gifre L; Vidal J; Carrasco JL; Filella X; Ruiz-Gaspà S; Muxi A; Portell E; Monegal A; Guañabens N; Peris P
    J Bone Miner Res; 2015 Jun; 30(6):1014-21. PubMed ID: 25484108
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Development of new syndesmophytes and bridges in ankylosing spondylitis and their predictors: a longitudinal study.
    van Tubergen A; Ramiro S; van der Heijde D; Dougados M; Mielants H; Landewé R
    Ann Rheum Dis; 2012 Apr; 71(4):518-23. PubMed ID: 21989544
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Physical function in ankylosing spondylitis is independently determined by both disease activity and radiographic damage of the spine.
    Landewé R; Dougados M; Mielants H; van der Tempel H; van der Heijde D
    Ann Rheum Dis; 2009 Jun; 68(6):863-7. PubMed ID: 18628283
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Distinct effect of zoledronate and clodronate on circulating levels of DKK1 and sclerostin in women with postmenopausal osteoporosis.
    Gatti D; Viapiana O; Idolazzi L; Fracassi E; Ionescu C; Dartizio C; Troplini S; Kunnathully V; Adami S; Rossini M
    Bone; 2014 Oct; 67():189-92. PubMed ID: 25003812
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Changes in bone formation regulator biomarkers in early axial spondyloarthritis.
    Descamps E; Molto A; Borderie D; Lories R; Richard CM; Pons M; Roux C; Briot K
    Rheumatology (Oxford); 2021 Mar; 60(3):1185-1194. PubMed ID: 32888036
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Excessive bone formation in a mouse model of ankylosing spondylitis is associated with decreases in Wnt pathway inhibitors.
    Haynes KR; Pettit AR; Duan R; Tseng HW; Glant TT; Brown MA; Thomas GP
    Arthritis Res Ther; 2012 Nov; 14(6):R253. PubMed ID: 23171658
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.